Clinical trial
Safety and Tolerability of GWP42006 in Children and Young Adults With Autism Spectrum Disorder
NCT03849456 is registered in ClinicalTrials.gov with Jazz Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Tolerability of GWP42006 in Children and Young Adults With Autism Spectrum Disorder
- Lead sponsor
- Jazz Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 7, 2020
- Completion date
- May 26, 2020
- Enrollment
- 1 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.